Keywords: mgi, goes, 82m, spending, spree, usa, pharma
MGI goes on $82M spending spree
Article | 06 September 2004
The USA's MGI Pharma has shelled out $82 million in cash on twosimultaneously-announced acquisitions: Zycos for $50 million and Aesgen for $32 million, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
